News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-20 2:8:39 pm 2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors BusinessWire
2024-03-15 3:27:0 pm FDA Advisory Committee Votes in Favor of Bristol Myers Squibb’s and 2seventy bio’s Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy Business Wire
2024-03-07 3:16:42 am Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term Simply Wall St.
2024-03-06 3:13:46 am When Will 2seventy bio, Inc. (NASDAQ:TSVT) Turn A Profit? Simply Wall St.
2024-03-05 4:0:0 am 2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress Business Wire
2024-03-01 4:0:0 am 2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences Business Wire
2024-02-05 1:5:0 pm 2seventy bio to Participate in Upcoming Investor Conferences Business Wire
2024-02-05 3:59:0 am Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple Myeloma Based on KarMMa-3 Study Business Wire
2024-01-30 4:1:0 am 2seventy bio Announces New Strategic Path Forward Business Wire
   

Please consider a small donation if you think this website provides you with relevant information